Retatrutide 10mg (10 Vials / Kit)

Retatrutide is a first-in-class triple hormone receptor agonist that simultaneously activates GIP, GLP-1, and glucagon receptors. This tri-agonist approach represents a novel paradigm in metabolic research.

Preclinical and early clinical research suggests that the addition of glucagon receptor agonism to dual incretin activity may enhance energy expenditure and lipid metabolism beyond what is achievable with single or dual agonists.

For research use only. Not for human consumption. This product is intended solely for in vitro research and laboratory use.